Related Experiment Video
Updated: Feb 15, 2026

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
HNRNPH1 is required for rhabdomyosarcoma cell growth and survival
Yanfeng Li1, Jesse Bakke1, David Finkelstein2
1Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Abstract:
Rhabdomyosarcoma (RMS) is an aggressive and difficult to treat cancer characterized by a muscle-like phenotype. Although the average 5-y survival rate is 65% for newly diagnosed RMS, the treatment options for metastatic disease are limited in efficacy, with the 5-y survival rate plummeting to 30%. Heterogenous nuclear ribonucleoprotein H1 (HNRNPH1) is an RNA-binding protein that is highly expressed in many cancers, including RMS. To determine the role HNRNPH1 plays in RMS tumorigenesis, we investigated its expression and effect on growth in three cellular models of RMS: RD, RH30, and RH41 cells. Upon knockdown of HNRNPH1, growth of all cell lines was reduced, most likely through a combination of apoptosis and cell cycle arrest. We then recapitulated this finding by performing in vivo xenograft studies, in which knockdown of HNRNPH1 resulted in a reduction of tumor formation and growth. We used RNA sequencing to identify changes in gene expression after HNRNPH1 knockdown and found altered splicing of some oncogenes. Our data contribute to understanding the role of HNRNPH1 in RMS development.
Insights
Heterogenous nuclear ribonucleoprotein H1 (HNRNPH1) drives rhabdomyosarcoma (RMS) growth. Reducing HNRNPH1 levels inhibits RMS cell proliferation and tumor development by inducing apoptosis and cell cycle arrest.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Rhabdomyosarcoma (RMS) is an aggressive pediatric cancer with poor prognosis for metastatic disease.
- Heterogenous nuclear ribonucleoprotein H1 (HNRNPH1), an RNA-binding protein, is highly expressed in RMS.
- Current RMS treatments have limited efficacy, especially for advanced stages.
Purpose of the Study:
- To investigate the role of HNRNPH1 in RMS tumorigenesis.
- To determine the effect of HNRNPH1 knockdown on RMS cell growth and tumor development.
Main Methods:
- Investigated HNRNPH1 expression in RMS cell lines (RD, RH30, RH41).
- Performed HNRNPH1 knockdown studies in vitro and in vivo (xenografts).
- Utilized RNA sequencing to analyze gene expression changes post-HNRNPH1 knockdown.
Main Results:
- HNRNPH1 knockdown significantly reduced RMS cell proliferation.
- Knockdown induced apoptosis and cell cycle arrest in RMS cells.
- In vivo studies showed reduced tumor formation and growth upon HNRNPH1 knockdown.
- RNA sequencing revealed altered splicing of oncogenes following HNRNPH1 reduction.
Conclusions:
- HNRNPH1 plays a crucial role in RMS development and progression.
- Targeting HNRNPH1 may represent a potential therapeutic strategy for RMS.
- Further research into HNRNPH1-mediated splicing alterations is warranted for RMS treatment development.
More Related Videos
12:22A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
Published on: September 22, 2019
09:56Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
Published on: July 27, 2014
Related Concept Videos
Oxygen Requirements and Growth Patterns
Requirements for Human Life
Oxygen
Atmospheric air is only about 20 percent oxygen, but that oxygen is a key component of the chemical reactions that keep the body alive, including the reactions that produce ATP. Brain cells are susceptible to a lack of oxygen because they require a...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...
Proteins: Dietary Sources and Requirements
Energy-requiring Steps of Glycolysis